VELOXTAR

Serial Number 79354840
Registration 7497692
700

Registration Progress

Application Filed
Jun 24, 2022
Under Examination
Approved for Publication
Jan 23, 2024
Published for Opposition
Jan 23, 2024
Registered
Sep 10, 2024

Trademark Image

VELOXTAR

Basic Information

Serial Number
79354840
Registration Number
7497692
Filing Date
June 24, 2022
Registration Date
September 10, 2024
Published for Opposition
January 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 10, 2024
Registration
Registered
Classes
040 042

Rights Holder

Daicel Corporation

03
Address
3-1, Ofuka-cho, Kita-ku,
Osaka-shi Osaka 530-0011
JP

Ownership History

Daicel Corporation

Original Applicant
03
JP

Daicel Corporation

Owner at Publication
03
JP

Daicel Corporation

Original Registrant
03
JP

Legal Representation

Attorney
Leigh Ann Lindquist

USPTO Deadlines

Next Deadline
1883 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-10)
Due Date
September 10, 2030
Grace Period Ends
March 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Mar 14, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 26, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 25, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Dec 10, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 22, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Sep 10, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 26, 2024 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Aug 19, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Aug 5, 2024 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Aug 4, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Apr 29, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Apr 10, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Apr 10, 2024 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Feb 9, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jan 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 3, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 3, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 16, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 26, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 7, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 7, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 19, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 18, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 18, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 10, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 040
Custom manufacture of pharmaceuticals; custom manufacture of oral medicinal preparations in the form of tablets; custom manufacture of orally disintegrating tablet; providing information relating to custom manufacturing or processing of pharmaceuticals; printing, custom stamping and surface coating of medicinal preparations in the form of tablets; providing information relating to material treatment
Class 042
Research, development and testing of disintegrants for tablets and orally disintegrating tablets using the disintegrants; research, development and testing of rapidly disintegrating tablets and its manufacturing methods; testing of medicines; research and development of medicines; testing, inspection or research of medicines cosmetics or foods; chemical research; testing of chemicals; inspection in the field of chemistry for quality control purposes; scientific laboratory services; research and development of new products for others

Classification

International Classes
040 042